In the latest Radiologie Magazin Special Edition, Onur Özek, Managing Director of Mint Medical, discusses why lung cancer screening is far more than the interpretation of a single examination:

“Screening is a process – and it requires an end-to-end platform.”

In the interview, he explains the requirements that Germany’s screening program places on radiology, IT infrastructure, and organizational workflows, the role of structured reporting and AI, and why interoperability and integrated workflows are critical to the long-term success of screening networks.

“It is not enough to deploy individual technologies. What matters is that all processes work together seamlessly and are integrated into existing IT infrastructures such as RIS and PACS.”

Topics Covered in the Interview

What role does AI play in lung cancer screening?

AI supports the detection and analysis of pulmonary nodules. However, the key factor is the integration of AI-generated results into the clinical workflow.

Why is interoperability important?

Screening programs connect primary readers, second-reading centers, and registries. Without standardized data exchange, workflow disruptions and inefficiencies can occur.

How does mint Lesion support radiologists in lung cancer screening?

mint Lesion supports radiologists in addressing key requirements of lung cancer screening—from structured reporting and AI-supported analysis to second-reader workflows and the longitudinal follow-up of screening participants.

Read the full interview in the current RadMag Special Edition on lung cancer screening.